advertisement
Shukla AG 22
Showing records 1 to 22 | Display all abstracts from Shukla AG108536 Scar formation in the presence of mitomycin C and the anti-fibrotic antibody in a rabbit model of glaucoma microsurgery: A pilot study
Shukla AG
Heliyon 2023; 9: e15368
108437 Correlation between Central Visual Field Defects and Stereopsis in Patients with Early-to-Moderate Visual Field Loss
Liu WW
Ophthalmology. Glaucoma 2023; 6: 493-500
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Wong JC; Wong JC
Ocular Immunology and Inflammation 2023; 0: 1-7
108536 Scar formation in the presence of mitomycin C and the anti-fibrotic antibody in a rabbit model of glaucoma microsurgery: A pilot study
Shukla AG
Heliyon 2023; 9: e15368
108437 Correlation between Central Visual Field Defects and Stereopsis in Patients with Early-to-Moderate Visual Field Loss
Shalaby WS; Shalaby WS
Ophthalmology. Glaucoma 2023; 6: 493-500
108536 Scar formation in the presence of mitomycin C and the anti-fibrotic antibody in a rabbit model of glaucoma microsurgery: A pilot study
Milman T
Heliyon 2023; 9: e15368
108437 Correlation between Central Visual Field Defects and Stereopsis in Patients with Early-to-Moderate Visual Field Loss
Shalaby WS
Ophthalmology. Glaucoma 2023; 6: 493-500
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Savsani E; Mahmoudzadeh R
Ocular Immunology and Inflammation 2023; 0: 1-7
108437 Correlation between Central Visual Field Defects and Stereopsis in Patients with Early-to-Moderate Visual Field Loss
Shiuey EJ
Ophthalmology. Glaucoma 2023; 6: 493-500
108536 Scar formation in the presence of mitomycin C and the anti-fibrotic antibody in a rabbit model of glaucoma microsurgery: A pilot study
Fertala J
Heliyon 2023; 9: e15368
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Salabati M
Ocular Immunology and Inflammation 2023; 0: 1-7
108536 Scar formation in the presence of mitomycin C and the anti-fibrotic antibody in a rabbit model of glaucoma microsurgery: A pilot study
Steplewski A
Heliyon 2023; 9: e15368
108437 Correlation between Central Visual Field Defects and Stereopsis in Patients with Early-to-Moderate Visual Field Loss
Raghu R
Ophthalmology. Glaucoma 2023; 6: 493-500
108536 Scar formation in the presence of mitomycin C and the anti-fibrotic antibody in a rabbit model of glaucoma microsurgery: A pilot study
Fertala A
Heliyon 2023; 9: e15368
108437 Correlation between Central Visual Field Defects and Stereopsis in Patients with Early-to-Moderate Visual Field Loss
Petkovsek D
Ophthalmology. Glaucoma 2023; 6: 493-500
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Razeghinejad R
Ocular Immunology and Inflammation 2023; 0: 1-7
108437 Correlation between Central Visual Field Defects and Stereopsis in Patients with Early-to-Moderate Visual Field Loss
Petkovsek D; Myers JS
Ophthalmology. Glaucoma 2023; 6: 493-500
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Lee D; Shukla AG
Ocular Immunology and Inflammation 2023; 0: 1-7
108437 Correlation between Central Visual Field Defects and Stereopsis in Patients with Early-to-Moderate Visual Field Loss
Wizov SS
Ophthalmology. Glaucoma 2023; 6: 493-500
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Shukla AG; Myers JS
Ocular Immunology and Inflammation 2023; 0: 1-7
108437 Correlation between Central Visual Field Defects and Stereopsis in Patients with Early-to-Moderate Visual Field Loss
Spaeth GL; Shukla AG; Shukla AG
Ophthalmology. Glaucoma 2023; 6: 493-500
107821 Glaucoma Surgical Outcomes in Patients with a History of Scleritis
Pro MJ; Moster MR; Dunn JP; Kolomeyer NN; Kolomeyer NN
Ocular Immunology and Inflammation 2023; 0: 1-7
